Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 713-792-6161
Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2011 - 2014
Harvard Medical SchoolClass of 2011
Certifications & Licensure
MA State Medical License 2023 - 2026
WA State Medical License 2017 - 2025
AK State Medical License 2018 - 2024
MT State Medical License 2022 - 2024
NY State Medical License 2012 - 2017
TX State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
- SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma Start of enrollment: 2021 Nov 11
Roles: Principal Investigator
- BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma Start of enrollment: 2024 Sep 30
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarco...Eyal Mor, Sameer Apte, Catherine Mitchell, Carolyn Nessim, Max Almond
Annals of Surgical Oncology. 2025-07-14 - Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.Vinayak Venkataraman, Hannah R Abrams, David S Shulman, Elizabeth T Loggers, Seth M Pollack
The Oncologist. 2025-07-04 - Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma.Erica M Pimenta, Anirudh Goyal, Orly N Farber, Elizabeth Lilley, Paul B Shyn
Current Treatment Options in Oncology. 2025-06-01
Press Mentions
How a Patient Partnership Is Propelling Cancer ResearchSeptember 14th, 2022- High COVID Complication Rates in Sarcoma PatientsNovember 12th, 2021
ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)May 21st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
